Pharma & Biotech

Olema Pharmaceuticals has scheduled a critical presentation for December, where the biotechnology firm will unveil progress from its OPERA-02 Phase...

The investment community is closely monitoring Hologic shares following a significant acquisition proposal. With private equity heavyweights making their move...

Investors in BioNTech are bracing for a pivotal moment as the biotechnology firm prepares to release its quarterly financial results....

CareDx shares are approaching a pivotal moment as the company navigates significant leadership changes and regulatory advancements. With fresh medical...

The Schwab U.S. Dividend Equity ETF™ is confronting persistent investor outflows as market sentiment shifts away from high-dividend strategies. Despite...

Assembly Biosciences has captured market attention with remarkable clinical trial results that propelled its shares upward by more than 25%...

The future of Kezar Life Sciences hangs in the balance following a devastating regulatory development that has forced the biotechnology...

The pharmaceutical firm Organon & Co. is confronting its most severe corporate challenge to date following the discovery of manipulated...

Biomea Fusion's stock remains under intense selling pressure, extending its downward trajectory for the fourth consecutive session. The equity declined...

Semler Scientific finds itself navigating treacherous waters as a potential rescue acquisition and substantial Bitcoin holdings fail to stem mounting...